Terms: = Lymphoma AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Diagnosis
20 results:
1. Diagnostic Utility of GATA3 and ISL1 in Differentiating Neuroblastoma From Other Pediatric Malignant Small Round Blue Cell Tumors.
Mohanty SK; Diwaker P; Mishra SK; Jha S; Lobo A; Panda SP; Sharma S; Kumar M; Arora S; Mallik V; Jain D; Jain E; Chakrabarti I; Varshney J; Beg A; Dixit M; Baisakh MR; Naik S; Sahoo SK; Akgul M; Balzer BL; Amin MB; Parwani AV
Int J Surg Pathol; 2024 Apr; 32(2):294-303. PubMed ID: 37312579
[TBL] [Abstract] [Full Text] [Related]
2. ALK Gene Mutation and ALK Protein Expression in Advanced Neuroblastoma and the Potential Value in Risk Stratification in Fine-Needle Aspiration Biopsy Samples.
Bhardwaj N; Rohilla M; Gautam U; Trehan A; Bansal D; Kakkar N; Srinivasan R
Am J Clin Pathol; 2023 Apr; 159(4):407-415. PubMed ID: 36812383
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases.
Bhatia P; Singh M; Singh A; Sharma P; Trehan A; Varma N
Int J Lab Hematol; 2021 Oct; 43(5):1016-1023. PubMed ID: 33538126
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic roles of and correlation between
Chang HH; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Hsu WM; Jeng YM; Jou ST
J Clin Pathol; 2020 Mar; 73(3):154-161. PubMed ID: 31542727
[TBL] [Abstract] [Full Text] [Related]
5. Too many targets, not enough patients: rethinking neuroblastoma clinical trials.
Fletcher JI; Ziegler DS; Trahair TN; Marshall GM; Haber M; Norris MD
Nat Rev Cancer; 2018 Jun; 18(6):389-400. PubMed ID: 29632319
[TBL] [Abstract] [Full Text] [Related]
6. Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse.
Chen L; Humphreys A; Turnbull L; Bellini A; Schleiermacher G; Salwen H; Cohn SL; Bown N; Tweddle DA
Oncotarget; 2016 Dec; 7(52):87301-87311. PubMed ID: 27888620
[TBL] [Abstract] [Full Text] [Related]
7. Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.
Bosse KR; Maris JM
Cancer; 2016 Jan; 122(1):20-33. PubMed ID: 26539795
[TBL] [Abstract] [Full Text] [Related]
8. Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at diagnosis.
Bellini A; Bernard V; Leroy Q; Rio Frio T; Pierron G; Combaret V; Lapouble E; Clement N; Rubie H; Thebaud E; Chastagner P; Defachelles AS; Bergeron C; Buchbinder N; Taque S; Auvrignon A; Valteau-Couanet D; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
Clin Cancer Res; 2015 Nov; 21(21):4913-21. PubMed ID: 26059187
[TBL] [Abstract] [Full Text] [Related]
9. Intrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastoma.
Jamin Y; Glass L; Hallsworth A; George R; Koh DM; Pearson AD; Chesler L; Robinson SP
PLoS One; 2014; 9(3):e92886. PubMed ID: 24667968
[TBL] [Abstract] [Full Text] [Related]
10. New insights into the genetics of neuroblastoma.
Sridhar S; Al-Moallem B; Kamal H; Terrile M; Stallings RL
Mol Diagn Ther; 2013 Apr; 17(2):63-9. PubMed ID: 23329364
[TBL] [Abstract] [Full Text] [Related]
11. Neonatal neuroblastoma.
Fisher JPH; Tweddle DA
Semin Fetal Neonatal Med; 2012 Aug; 17(4):207-215. PubMed ID: 22673527
[TBL] [Abstract] [Full Text] [Related]
12. Development of treatment strategies for advanced neuroblastoma.
Hara J
Int J Clin Oncol; 2012 Jun; 17(3):196-203. PubMed ID: 22588779
[TBL] [Abstract] [Full Text] [Related]
13. Adult neuroblastoma arising in the superior mediastinum.
Ohtaki Y; Ishii G; Hasegawa T; Nagai K
Interact Cardiovasc Thorac Surg; 2011 Aug; 13(2):220-2. PubMed ID: 21388984
[TBL] [Abstract] [Full Text] [Related]
14. Neuroblastoma: biology and staging.
Mueller S; Matthay KK
Curr Oncol Rep; 2009 Nov; 11(6):431-8. PubMed ID: 19840520
[TBL] [Abstract] [Full Text] [Related]
15. Fine needle biopsy and genetics, two allied weapons in the diagnosis, prognosis, and target therapeutics of solid pediatric tumors.
Barroca H
Diagn Cytopathol; 2008 Sep; 36(9):678-84. PubMed ID: 18677757
[TBL] [Abstract] [Full Text] [Related]
16. Analyses of novel prognostic factors in neuroblastoma patients.
Ootsuka S; Asami S; Sasaki T; Yoshida Y; Nemoto N; Shichino H; Chin M; Mugishima H; Suzuki T
Biol Pharm Bull; 2007 Dec; 30(12):2294-9. PubMed ID: 18057715
[TBL] [Abstract] [Full Text] [Related]
17. Association between congenital cardiovascular malformations and neuroblastoma.
George RE; Lipshultz SE; Lipsitz SR; Colan SD; Diller L
J Pediatr; 2004 Apr; 144(4):444-8. PubMed ID: 15069390
[TBL] [Abstract] [Full Text] [Related]
18. Cytogenetics and tissue culture of small round cell tumors of bone and soft tissue.
Noguera R
Semin Diagn Pathol; 1996 Aug; 13(3):171-83. PubMed ID: 8875708
[TBL] [Abstract] [Full Text] [Related]
19. Two malignant peripheral primitive neuroepithelial tumor cell lines established from consecutive samples of one patient: characterization and cytogenetic analysis.
Kees UR; Rudduck C; Ford J; Spagnolo D; Papadimitriou J; Willoughby ML; Garson OM
Genes Chromosomes Cancer; 1992 Apr; 4(3):195-204. PubMed ID: 1382559
[TBL] [Abstract] [Full Text] [Related]
20. [Detection of early stage cancer: pathological aspect with special reference to differential diagnosis].
Tanaka N
Gan No Rinsho; 1988 Aug; 34(10):1255-8. PubMed ID: 3172485
[TBL] [Abstract] [Full Text] [Related]
